-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

--Credit Suisse Starts NewAmsterdam Pharma at Outperform With $21 Price Target

--Credit Suisse Starts NewAmsterdam Pharma at Outperform With $21 Price Target

MT Newswires · 01/06/2023 03:27